Skip to main content
Yunkang Group Limited logo

Yunkang Group Limited — Investor Relations & Filings

Ticker · 2325 ISIN · KYG9889T1067 HKEX Human health and social work activities
Open in API
Filings indexed 1,526 across all filing types
Latest filing 2024-03-28 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2325

About Yunkang Group Limited

http://www.yunkanghealth.com

Yunkang Group Limited is a leading medical operation service platform specializing in standardized medical diagnostic services. The company provides comprehensive clinical diagnostic capabilities to collaborative hospitals and integrated healthcare systems (hospital alliances). Its core business lines include diagnostic testing services and diagnostic outsourcing services for medical institutions, as well as diagnostic testing for non-medical clients. Yunkang leverages a nationwide service network and operates independent clinical laboratories (ICLs) across key regions. These ICLs often hold dual international accreditations, such as ISO15189 and CAP, ensuring high-quality, full-range clinical diagnostic support.

Recent filings

Filing Released Lang Actions
RENEWAL OF CONTINUING CONNECTED TRANSACTIONS WITH FUJITSU
Regulatory Filings Classification · 95% confidence The document is an announcement from Lenovo Group Limited regarding the renewal of continuing connected transactions with Fujitsu. It details the terms, parties, scope, pricing, historical transaction amounts, and new annual caps of various agreements between the companies. The content focuses on corporate transactions and compliance with listing rules, specifically Chapter 14A of the Hong Kong Listing Rules, which governs connected transactions. There is no presentation of financial statements, audit opinions, earnings highlights, or management discussion of financial results. The document is a formal announcement of ongoing contractual relationships and their renewal, including regulatory implications and approvals by the board. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about connected transactions and compliance, not a full financial report or earnings release. The document length (15,000 characters) and detailed content confirm it is not a brief report publication announcement or a simple notice. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-03-28 English
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2023
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Cash Dividend Announcement for Equity Issuer' and provides detailed information about a final dividend for the year ended 31 December 2023, including dividend amount, record date, ex-dividend date, and payment details. It does not contain financial statements or management discussion but is an announcement specifically about dividend details. The document length is 3128 characters, which is relatively short and focused solely on dividend information. Therefore, it fits the category of 'Notice of Dividend Amount' (DIV) rather than a full financial report or other announcement types.
2024-03-25 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Annual Report Classification · 95% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023' and contains detailed audited consolidated financial results, including comprehensive income statements, financial position statements, and notes to the consolidated financial statements. It covers the full fiscal year ending December 31, 2023, and includes extensive financial data and analysis. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of detailed financial statements and notes confirms it is an official yearly report covering company activity and full financial performance. Therefore, this document fits the definition of an Annual Report (10-K). FY 2023
2024-03-25 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 95% confidence The document is a short announcement from Yunkang Group Limited stating the date of a forthcoming board meeting to approve and publish the annual results for the year ended December 31, 2023, and to consider the payment of a final dividend. It does not contain any actual financial data or detailed report content. The length is only 1375 characters, which is quite short and typical for an announcement rather than a full report. The document explicitly states the meeting will approve and publish the annual results, indicating the report itself is not included here. Therefore, this document is an announcement about the timing of a report publication, not the report itself. According to the rules, such documents are classified as Report Publication Announcement (RPA).
2024-03-13 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 29 FEBRUARY 2024
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 29 February 2024. It details movements in authorized/registered share capital, issued shares, and confirms no changes in share options, warrants, convertibles, or other agreements. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share issuance status. It is not a financial report, earnings release, or management discussion. It is a regulatory filing reporting share capital and share movements as required by exchange rules. The document length is 4437 characters, which is relatively short and consistent with a regulatory filing rather than a full report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-03-06 English
PROFIT WARNING
Regulatory Filings Classification · 95% confidence The document is titled 'PROFIT WARNING' and is an announcement by Yunkang Group Limited regarding an expected net loss for the year ended December 31, 2023, based on preliminary unaudited consolidated management accounts. It references the Listing Rules of the Hong Kong Stock Exchange and the Securities and Futures Ordinance. The document explicitly states that the financial data is unaudited and preliminary, and advises shareholders to await the formal annual results announcement expected in March 2024. The document is relatively short (4402 characters) and serves as a cautionary announcement about expected financial performance rather than a full financial report. It does not contain detailed financial statements or substantive financial data but rather a summary and warning about expected results. This fits the profile of a Regulatory Filing (RNS) as it is a regulatory announcement about expected financial performance and caution to investors, not the actual annual report or earnings release.
2024-03-05 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.